Drugs / PandemrixTM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01160237 | Aug 2010 → Feb 2011 | influenza | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pandemrix TM | “The aim of this study is to evaluate the immune response and the safety of one injection of FluarixTM/ Influsplit SSW® 2010/2011 or Pandemrix TM in subjects who had received a...” NCT01160237 ↗ |
| Modality | Vaccine | “a vaccine against the pandemic H1N1 strain” NCT01160237 ↗ |
| Route | Intramuscular | “One dose intramuscular injection” NCT01160237 ↗ |